166 related articles for article (PubMed ID: 10837647)
1. ISCOMs and other saponin based adjuvants.
Cox JC; Sjölander A; Barr IG
Adv Drug Deliv Rev; 1998 Jul; 32(3):247-271. PubMed ID: 10837647
[TBL] [Abstract][Full Text] [Related]
2. Uptake and adjuvant activity of orally delivered saponin and ISCOM vaccines.
Sjölander A; Cox JC
Adv Drug Deliv Rev; 1998 Dec; 34(2-3):321-338. PubMed ID: 10837684
[TBL] [Abstract][Full Text] [Related]
3. ISCOMs: an adjuvant with multiple functions.
Sjölander A; Cox JC; Barr IG
J Leukoc Biol; 1998 Dec; 64(6):713-23. PubMed ID: 9850152
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterisation of quillaja saponin with less heterogeneity than Quil-A.
Kamstrup S; San Martin R; Doberti A; Grande H; Dalsgaard K
Vaccine; 2000 Apr; 18(21):2244-9. PubMed ID: 10717344
[TBL] [Abstract][Full Text] [Related]
5. Advances in saponin-based adjuvants.
Sun HX; Xie Y; Ye YP
Vaccine; 2009 Mar; 27(12):1787-96. PubMed ID: 19208455
[TBL] [Abstract][Full Text] [Related]
6. Saponin Interactions with Model Membrane Systems - Langmuir Monolayer Studies, Hemolysis and Formation of ISCOMs.
de Groot C; Müller-Goymann CC
Planta Med; 2016 Dec; 82(18):1496-1512. PubMed ID: 27760443
[TBL] [Abstract][Full Text] [Related]
7. Formulation of IMXQB: Nanoparticles Based on Quillaja brasiliensis Saponins to be Used as Vaccine Adjuvants.
Rivera-Patron M; Cibulski SP; Miraballes I; Silveira F
Methods Mol Biol; 2022; 2469():183-191. PubMed ID: 35508839
[TBL] [Abstract][Full Text] [Related]
8. Novel Oxime-Derivatized Synthetic Triterpene Glycosides as Potent Saponin Vaccine Adjuvants.
Fuentes R; Aguinagalde L; Pifferi C; Plata A; Sacristán N; Castellana D; Anguita J; Fernández-Tejada A
Front Immunol; 2022; 13():865507. PubMed ID: 35603193
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.
Rönnberg B; Fekadu M; Morein B
Vaccine; 1995 Oct; 13(14):1375-82. PubMed ID: 8585296
[TBL] [Abstract][Full Text] [Related]
10. A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge.
Yendo AC; de Costa F; Cibulski SP; Teixeira TF; Colling LC; Mastrogiovanni M; Soulé S; Roehe PM; Gosmann G; Ferreira FA; Fett-Neto AG
Vaccine; 2016 Apr; 34(20):2305-11. PubMed ID: 27032516
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant activity of saponins from Kazakhstani plants on the immune responses to subunit influenza vaccine.
Turmagambetova AS; Alexyuk PG; Bogoyavlenskiy AP; Zaitseva IA; Omirtaeva ES; Alexyuk MS; Sokolova NS; Berezin VE
Arch Virol; 2017 Dec; 162(12):3817-3826. PubMed ID: 28936557
[TBL] [Abstract][Full Text] [Related]
12. Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms.
Behboudi S; Morein B; Rönnberg B
Vaccine; 1995 Dec; 13(17):1690-6. PubMed ID: 8719521
[TBL] [Abstract][Full Text] [Related]
13. Immunostimulating complexes incorporating Eimeria tenella antigens and plant saponins as effective delivery system for coccidia vaccine immunization.
Berezin VE; Bogoyavlenskiy AP; Tolmacheva VP; Makhmudova NR; Khudyakova SS; Levandovskaya SV; Omirtaeva ES; Zaitceva IA; Tustikbaeva GB; Ermakova OS; Aleksyuk PG; Barfield RC; Danforth HD; Fetterer RH
J Parasitol; 2008 Apr; 94(2):381-5. PubMed ID: 18564738
[TBL] [Abstract][Full Text] [Related]
14. Adjuvanticity and ISCOM formation by structurally diverse saponins.
Bomford R; Stapleton M; Winsor S; Beesley JE; Jessup EA; Price KR; Fenwick GR
Vaccine; 1992; 10(9):572-7. PubMed ID: 1502835
[TBL] [Abstract][Full Text] [Related]
15. Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity.
Rönnberg B; Fekadu M; Behboudi S; Kenne L; Morein B
Vaccine; 1997 Dec; 15(17-18):1820-6. PubMed ID: 9413088
[TBL] [Abstract][Full Text] [Related]
16. Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer.
Ragupathi G; Gardner JR; Livingston PO; Gin DY
Expert Rev Vaccines; 2011 Apr; 10(4):463-70. PubMed ID: 21506644
[TBL] [Abstract][Full Text] [Related]
17. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity.
Marciani DJ; Press JB; Reynolds RC; Pathak AK; Pathak V; Gundy LE; Farmer JT; Koratich MS; May RD
Vaccine; 2000 Jul; 18(27):3141-51. PubMed ID: 10856794
[TBL] [Abstract][Full Text] [Related]
18. In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids.
Behboudi S; Morein B; Villacres-Eriksson M
Clin Exp Immunol; 1996 Jul; 105(1):26-30. PubMed ID: 8697631
[TBL] [Abstract][Full Text] [Related]
19. QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation Into Liposomes.
Brunner L; Barnier-Quer C; Collin N
Methods Mol Biol; 2017; 1494():73-86. PubMed ID: 27718186
[TBL] [Abstract][Full Text] [Related]
20. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
